Control Bionics

Control Bionics Net Debt / EBITDA

The Net Debt to EBITDA of Control Bionics (CBL.AX) as of Oct 14, 2026 is 0.03.

Net Debt / EBITDA

0.03

YoY

754.07%

Last updated:

Net Debt to EBITDA of Control Bionics is 2025 0.03 . Net Debt to EBITDA of Control Bionics was 2024 0.00 . It decreases by 754.07% higher compared to the previous year.

The Control Bionics Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2018
1.90 AUD
Jan 1, 2019
0.42 AUD
Jan 1, 2020
1.30 AUD
Jan 1, 2021
4.18 AUD
Jan 1, 2022
0.88 AUD
Jan 1, 2023
0.17 AUD
Jan 1, 2024
0.00 AUD
Jan 1, 2025
0.03 AUD
The Control Bionics Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
0.03+754.07%
0.00-97.78%
0.17-80.53%
0.88-79.04%
4.18+222.38%
1.30+211.67%
0.42-78.15%
1.90—
Access this data via the Eulerpool API
Get Free API Key

Control Bionics Stock analysis

What does Control Bionics do? Control Bionics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Control Bionics stock

Net Debt to EBITDA of Control Bionics is 0.03 in 2025.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA Control Bionics since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Control Bionics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Leverage — Control Bionics

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Control Bionics